---
title: "RLAY.US (RLAY.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/RLAY.US/news.md"
symbol: "RLAY.US"
name: "RLAY.US"
parent: "https://longbridge.com/en/quote/RLAY.US.md"
datetime: "2026-05-20T06:10:38.670Z"
locales:
  - [en](https://longbridge.com/en/quote/RLAY.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RLAY.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RLAY.US/news.md)
---

# RLAY.US (RLAY.US) — Related News

### [Relay Therapeutics Reports Early Success For Investigational Drug In Rare Vascular Disorders](https://longbridge.com/en/news/286947243.md)
*2026-05-19T16:48:53.000Z*
> Relay Therapeutics reported promising early Phase 2 data for zovegalisib, showing lesion reduction and symptom improveme

### [](https://longbridge.com/en/news/286905297.md)
*2026-05-19T11:34:56.000Z*
> Relay Therapeutics shares are trading higher after the company announced initial clinical data from the Phase 2 ReInspir

### [This Biotech's Drug Just Wiped The Floor With Forecasts](https://longbridge.com/en/news/286904878.md)
*2026-05-19T11:21:23.000Z*
> Relay Therapeutics exceeded Wall Street's expectations on Tuesday with its experimental treatment for vascular anomalies